Lunai Bioworks (LNAI) EBIT (QoQ) (2011 - 2026)
Lunai Bioworks (LNAI) EBIT (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Lunai Bioworks | 6.94 Mn | 3.78 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.98% |
| Dec 31, 2025 | 44.88% |
| Sep 30, 2025 | 97.39% |
| Jun 30, 2025 | -2,949.10% |
| Mar 31, 2025 | 8.44% |
| Dec 31, 2024 | 91.48% |
| Sep 30, 2024 | -211.84% |
| Jun 30, 2024 | 66.71% |
| Mar 31, 2024 | -1,103.28% |
| Dec 31, 2023 | 51.94% |
| Sep 30, 2023 | 61.26% |
| Jun 30, 2023 | -464.42% |
| Mar 31, 2023 | 6.97% |
| Dec 31, 2022 | 39.26% |
| Sep 30, 2022 | 92.68% |
| Jun 30, 2022 | -2,334.20% |
| Mar 31, 2022 | 36.27% |
| Dec 31, 2021 | 15.64% |
| Sep 30, 2021 | 47.09% |
| Jun 30, 2021 | -364.45% |